(Q44443182)

3 December 2017

title

Mechanisms for T-cell selective cytotoxicity of arabinosylguanine (English)

1 reference

3 December 2017

0 references

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2003-01-0317

3 January 2024

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2003-01-0317

3 January 2024

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2003-01-0317

3 January 2024

Carlos O. Rodriguez

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12750168

3 January 2024

Varsha Gandhi

1 reference

3 December 2017

Christine M. Stellrecht

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12750168

3 January 2024

language of work or name

English

0 references

publication date

15 May 2003

1 reference

full work available at URL

3 December 2017

http://ashpublications.org/blood/article-pdf/102/5/1842/1690013/h81703001842.pdf

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2003-01-0317

3 January 2024

1 reference

3 December 2017

volume

102

1 reference

3 December 2017

1 reference

3 December 2017

page(s)

1842-1848

1 reference

Nucleoside-phosphorylase deficiency in a child with severely defective T-cell immunity and normal B-cell immunity

3 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2003-01-0317

Deoxyguanosine toxicity in a mouse T lymphoma: Relationship to purine nucleoside phosphorylase-associated immune dysfunction

3 January 2024

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2003-01-0317

The metabolism of deoxyguanosine and guanosine in human B and T lymphoblasts. A role for deoxyguanosine kinase activity in the selective T-cell defect associated with purine nucleoside phosphorylase deficiency

3 January 2024

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2003-01-0317

Lymphospecific toxicity in adenosine deaminase deficiency and purine nucleoside phosphorylase deficiency: Possible role of nucleoside kinase(s)

3 January 2024

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2003-01-0317

Deoxyguanosine Triphosphate as a Possible Toxic Metabolite in the Immunodeficiency Associated with Purine Nucleoside Phosphorylase Deficiency

3 January 2024

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2003-01-0317

Purinogenic immunodeficiency diseases: selective toxicity of deoxyribonucleosides for T cells

3 January 2024

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2003-01-0317

Biological activities of some purine arabinosides

3 January 2024

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2003-01-0317

Purine nucleoside modulation of functions of human lymphocytes

3 January 2024

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2003-01-0317

Specific cytotoxicity of arabinosylguanine toward cultured T lymphoblasts

3 January 2024

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2003-01-0317

Metabolism and selectivity of arabinonucleoside in human lymphoid cells

3 January 2024

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2003-01-0317

Compound GW506U78 in refractory hematologic malignancies: relationship between cellular pharmacokinetics and clinical response

3 January 2024

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2003-01-0317

Evaluation of the combination of nelarabine and fludarabine in leukemias: clinical response, pharmacokinetics, and pharmacodynamics in leukemia cells

3 January 2024

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2003-01-0317

Arabinosyl nucleosides. XXXII. Mechanism of inhibition of L5178y mouse lymphoma cells by 9-beta-D-arabinofuranosylguanine

3 January 2024

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2003-01-0317

Involvement of the CD95 (APO–1/Fas) receptor/ligand system in drug–induced apoptosis in leukemia cells

3 January 2024

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2003-01-0317

Release of preformed Fas ligand in soluble form is the major factor for activation-induced death of Jurkat T cells

3 January 2024

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2003-01-0317

Expression of the functional soluble form of human fas ligand in activated lymphocytes.

3 January 2024

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2003-01-0317

Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family

3 January 2024

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2003-01-0317

Autocrine T-cell suicide mediated by APO-1/(Fas/CD95)

3 January 2024

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2003-01-0317

Metalloproteinase-mediated release of human Fas ligand

3 January 2024

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2003-01-0317

p53, the cellular gatekeeper for growth and division

3 January 2024

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2003-01-0317

Frequent mutations in the p53 tumor suppressor gene in human leukemia T-cell lines

3 January 2024

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2003-01-0317

Induction of apoptotic program in cell-free extracts: requirement for dATP and cytochrome c

3 January 2024

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2003-01-0317

Induction of an apoptotic program in cell-free extracts by 2-chloro-2'-deoxyadenosine 5'-triphosphate and cytochrome c

3 January 2024

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2003-01-0317

Nucleotide requirements for the in vitro activation of the apoptosis protein-activating factor-1-mediated caspase pathway

3 January 2024

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2003-01-0317

Activation of apoptosis pathways by anticancer treatment.

3 January 2024

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2003-01-0317

Fas gene mutations in the Canale-Smith syndrome, an inherited lymphoproliferative disorder associated with autoimmunity

3 January 2024

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2003-01-0317

Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome

3 January 2024

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2003-01-0317

Deficient activation of the CD95 (APO-1/Fas) system in drug-resistant cells

3 January 2024

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2003-01-0317

c-Jun-dependent CD95-L expression is a rate-limiting step in the induction of apoptosis by alkylating agents

3 January 2024

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2003-01-0317

Mutations in Fas associated with human lymphoproliferative syndrome and autoimmunity

3 January 2024

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2003-01-0317

T cell differentiation: a mechanistic view

3 January 2024

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2003-01-0317

B cell development and differentiation

3 January 2024

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2003-01-0317

Regulation of granulopoiesis by transcription factors and cytokine signals

3 January 2024

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2003-01-0317

3 January 2024

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2003-01-0317

Resistance to mitochondrial- and Fas-mediated apoptosis in human leukemic cells with acquired resistance to 9-beta-D-arabinofuranosylguanosine

3 January 2024

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2003-01-0317

3 January 2024

Fas ligand, death gene.

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2003-01-0317

DNA damaging agents induce expression of Fas ligand and subsequent apoptosis in T lymphocytes via the activation of NF-kappa B and AP-1.

3 January 2024

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2003-01-0317

A novel AP-1 element in the CD95 ligand promoter is required for induction of apoptosis in hepatocellular carcinoma cells upon treatment with anticancer drugs

3 January 2024

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2003-01-0317

Autoamplification of apoptosis following ligation of CD95-L, TRAIL and TNF-α

3 January 2024

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2003-01-0317

3 January 2024

Identifiers

DOI

1 reference

3 December 2017

1 reference